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An outbreak of methicillin-resistant Staphylococcus aureus infections at the University of Utah Health
Sciences Center occurred over a 7-month period. While the isolates phenotypically appeared to be similar in
gross morphology and have similar Vitek antibiotic susceptibility patterns, two additional methods of strain
characterization were evaluated to enhance the epidemiological investigation: pulsed-field gel electrophoresis
and gas chromatography with the MIDI Sherlock system. Sherlock uses gas chromatography to qualitatively
and quantitatively analyze the cellular fatty acid composition of organisms and creates two-dimensional plots
based on principal-component analysis to define groups of closely related organisms. All isolates were also
evaluated by digesting their chromosomal DNAs with the low-frequency-cutting enzyme SmaI and separating
the restriction fragments by contour-clamped homogeneous electric field gel electrophoresis. Sample prepa-
ration for this pulsed-field gel electrophoresis included a novel cell lysis procedure involving achromopepti-
dase, greatly reducing the turnaround time. Isolates tested were recovered from the following: 45 suspected
outbreak patients, 6 hospitalized patients believed to be unrelated to the outbreak, 6 patients from outside the
hospital, and one health care practitioner implicated in the outbreak. Of 45 phenotypically similar suspect
strains, 43 clustered tightly on the Sherlock two-dimensional plot. All outbreak patient isolates were also
identical by pulsed-field gel electrophoresis with the exception of the same two outliers identified by Sherlock.
In this epidemiologic investigation, we found an excellent correlation between the Sherlock and pulsed-field gel
electrophoresis results for strain characterization of methicillin-resistant S. aureus.
Methicillin-resistant Staphylococcus aureus (MRSA) re-
mains an important cause of nosocomial infections (13). Na-
tionally, 5 to 10% of all hospitalized patients in a given facility
become colonized or infected with MRSA (14). Outbreaks of
MRSA in an institution may be difficult to evaluate because of
MRSA endemicity and limited evolutionary diversity (11).
Over a 7-month period, the University of Utah Health Sci-
ences Center (UUHSC) experienced an outbreak of MRSA
infections. Isolates were available from 45 patients in the med-
ical and surgical intensive care, burn, and rehabilitation units.
Traditional tracking methods involving antibiograms were
strongly indicative of single-strain involvement. Therefore, the
outbreak was thought to be well defined and an excellent
opportunity to evaluate methods of epidemiologic typing.
Although analysis of cellular fatty acids (CFA), especially by
the MIDI Sherlock system, is well established as a tool for
identification of unusual and novel isolates in the clinical lab-
oratory (5, 26, 30, 35), we believed Sherlock’s capacity to com-
pare large numbers of isolates to be an underutilized advan-
tage. We decided to challenge the system’s strain tracking
ability with isolates from this well-defined outbreak.
Numerous investigators have demonstrated the superiority
of macrorestriction analysis by using pulsed-field gel electro-
phoresis (PFGE) for strain characterization compared with
techniques such as plasmid profiling (9), restriction enzyme
analysis of plasmid DNA (3), ribotyping (23), amplification of
randomly primed DNA (27), or zymotyping, phage typing, and
capsular typing (28). These techniques are summarized in re-
views by Maslow et al. (15) and Tenover et al. (32). We have
developed a time-efficient method, applicable to a clinical lab-
oratory’s work flow, for preparing S. aureus lysates for PFGE.
This method was chosen as a reference standard.
MATERIALS AND METHODS
Bacterial isolates. The hospital epidemiology staff performed an epidemio-
logic investigation involving the medical, surgical, neurosurgical, and burn-
trauma intensive care units and the general surgery, psychiatry, and rehabilita-
tion units. They identified the initial body site of colonization for each of the
patients thought to be associated with the outbreak. Isolates from the following
specimens were chosen for study: sputum (n 5 20), blood (n 5 2), surgical
wounds (n5 1), intravenous catheter tips (n5 3), decubitus ulcers (n5 2), urine
(n 5 3), peritoneal fluid (n 5 2), and, as the outbreak progressed into the burn
unit, Rodac cultures from a variety of body sites (n5 12). Isolates were identified
as S. aureus by the Staphaurex test (Murex Diagnostics Limited, Dartford, En-
gland). Six knownMRSA isolates from patients thought not to be associated with
the outbreak were also included. Six isolates from patients other than those at
the UUHSC were used as a control group, including three patients from else-
where in the Salt Lake Valley and three from areas outside Utah (Arizona,
Hawaii, and Kansas). One isolate was cultured from the hands of a respiratory
therapist suspected to be involved in the spread of the outbreak.
Antibiograms. All patient isolates were initially screened with Vitek GPS-SA
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cards (Bio-Merieux Vitek, Inc. Hazelwood, Mo.) and on Mueller-Hinton
agar supplemented with 2% NaCl and 6 mg of oxacillin per ml. The Vitek AMS
instrument automatically edits the results obtained with b-lactam antibiotics to
report resistance when oxacillin resistance is detected. The Kirby-Bauer disk
diffusion method was also performed in accordance with National Committee for
Clinical Laboratory Standards guidelines (20) to obtain a more complete sus-
ceptibility profile of each isolate. Mueller-Hinton agar for Kirby-Bauer testing
was purchased from BBL, Cockeysville, Md. Disks were from Becton-Dickinson,
Cockeysville, Md. The antibiotics tested are listed in Table 1.
Sherlock. Sherlock uses gas chromatography to qualitatively and quantitatively
analyze the CFA composition of organisms. All 58 isolates were sent to MIDI for
analysis. The samples were labeled with stock numbers only, essentially blinding
the collection for MIDI.
Instrument configuration and organism growth and hydrolysis were those
described in the Sherlock protocol (the latest version of the previously described
[17] MIDI Microbial Identification System). Briefly, one heaping 4-mm loopful
of overnight growth was used to coat the bottom of a glass screw-cap tube (13 by
100 mm). All reagents for saponification, methylation, extraction, and washing
were dispensed with autopipets into this same tube, making the hands-on time
minimal. Up to 45 samples can be prepared in approximately 3.5 h. The instru-
ment can classify one sample every 30 min and is totally automated; i.e., the
samples are generally left to run overnight.
Peak naming and organism identification were similar to those previously
described (35), except that Sherlock utilizes the Hewlett-Packard 3365 GC
ChemStation for sample handling and analysis. Cluster analysis of the data
generated was performed with the MIDI Library Generation Software, which
includes a principal-component two-dimensional plot program based on compo-
nents responsible for the greatest degree of variability among the isolates tested
(18, 25).
PFGE. (i) Plug preparation. Isolates to be tested were recovered from frozen
stocks and subcultured twice on Columbia agar with 5% sheep erythrocytes
(BBL). A single colony was selected and grown overnight in tryptic soy broth at
378C with agitation. A 500-ml aliquot of the broth growth (adjusted to equal a 3.0
McFarland density standard) was pelleted by centrifugation and washed in 1 ml
of TEN (0.1 M Tris, 0.1 M EDTA, 0.15 M NaCl, pH 7.5) and then in 1 ml of TN
(10 mM Tris, 10 mM NaCl, pH 8.0). The final pellet was resuspended in 100 ml
of TN and mixed with 100 ml of TN containing 2% InCert agarose (FMC
BioProducts, Rockland, Maine) and 6 ml of achromopeptidase (ACP; 20 U/ml;
Wako BioProducts, Richmond, Va.). This suspension was sufficient to fill two
wells of a Bio-Rad disposable plug mold (Bio-Rad Laboratories, Hercules, Ca-
lif.). The plugs were kept at 48C for 10 min, expelled into 300 ml of TN,
transferred to a 508C water bath, and kept there for 30 min. The lysed plugs were
washed twice in 2 ml of TE (10 mM Tris, 1 mM EDTA, pH 7.5) at room
temperature with agitation for 30 min each time. Plugs were stored at 48C in TE
or processed immediately for restriction enzyme digestion.
(ii) Restriction endonuclease digestion. One-hundred-microliter plugs were
cut in half, resulting in 50-ml agarose blocks of approximately 2.5 by 10 mm.
Alternately, large numbers of isolates could be processed by cutting the plugs in
fourths. The blocks were transferred to a 200-ml aliquot of NEBuffer 4 (New
England BioLabs, Beverly, Mass.) containing 2 ml (20 U) of the enzyme SmaI
(New England BioLabs). A previously prepared and lysed plug (or a plug pur-
chased from Bio-Rad) containing S. aureus NCTC 8325 was included as a control
for the endonuclease. Digestion was complete in 2 h at room temperature.
(iii) Contour-clamped homogeneous electric field gel electrophoresis. Sample
blocks were placed in 1 ml of 0.53 TBE (50 mM Tris, 50 mM H3BO3, 0.5 mM
EDTA) for at least 30 min before being embedded in a 1.2% GTG agarose gel
(FMC). Bacteriophage lambda DNA concatemers (Lambda Ladder PFG Mark-
er; New England BioLabs) were embedded in a similar fashion and used as size
standards. Restriction fragments were separated over a size range of approxi-
mately 50 to 700 kb by contour-clamped homogeneous electric field gel electro-
phoresis in 0.53 TBE on a CHEF Mapper (Bio-Rad). The CHEF Mapper was
programmed with a voltage gradient of 6 V/cm and a switch time ramped linearly
from 15 to 55 s over 22 h. Gels were stained with ethidium bromide and imaged
by UV transillumination to Polaroid film.
RESULTS
The results of Kirby-Bauer susceptibility testing are in Table
1. With the exception of slight variability in amikacin zone sizes
that straddled the interpretative breakpoints, the outbreak
strains were very similar. Resistance to trimethoprim-sulfame-
thoxazole evolved as a marker for this group. Two strains
originally thought to be epidemiologically associated clearly
showed discrepant susceptibility patterns, one due primarily to
trimethoprin-sulfamethoxazole susceptibility. Two isolates not
known to be associated had patterns consistent with the out-
TABLE 1. Results of Kirby-Bauer susceptibility testing of all 58 isolates
Isolate source
Zone of inhibition (mm)a
AN CZ OFX CC E GM OX P Te SXT NN VA
Outbreak 14 (13–18)b 9 (6–12)b 20 (18–24)b 19 (17–20)b
UUHSC employees 13 8 25 18
UUHSC outpatient clinic 20 11 31 19
Non-outbreak-associated UUHSC site 14 18 24 29 18
Non-outbreak-associated UUHSC site 13 18 21 29 31 18
Non-outbreak-associated UUHSC site 14 10 20 25 28 18
Non-outbreak-associated UUHSC site 14c 8 21 19
Non-outbreak-associated UUHSC site 21 28 23 25 27 22 17d 13 26 27 22 21
Non-outbreak-associated UUHSC site 14 25 27 7 22 27 32 19
Non-UUHSC sites
Salt Lake City physician’s laboratory 14 19 25 31 19
Salt Lake City hospital 14 19 26 30 18
Arizona 19 24 25 24 22 19 16d 12 26 37 20 18
Hawaii 19 21 23 24 19 25 26 20 18
Kansas 18 8 12 26 10 20
Possibly epidemiologically associated
UUHSC site
16 7 20 25 30 19
Possibly epidemiologically associated
UUHSC site
18 24 25 24 24 20 20e 26 28 21 18
a Boxed areas indicate no zone of inhibition. Shading indicates hazy growth up to OX disk. Antibiotic disk abbreviations: AN, amikacin; CC, clindamycin, OX,
oxacillin; SXT, trimethoprim-sulfamethoxazole; CZ, cefazolin; E, erythromycin; P, penicillin; NN, tobramycin; OFX, ofloxacin; GM, gentamicin, TE, tetracycline; VA,
vancomycin.
bMedian and range of values for 43 outbreak isolates.
c Sherlock and PFGE results indistinguishable from those of outbreak strains.
d b-Lactamase-hyperproduction; light growth on oxacillin agar screening plate.
e b-Lactamase (nitrocefin) negative at 1 h.
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break (one from a nonassociated inpatient and one from an
outpatient clinic.)
The Sherlock clustering, based on principal-component
analysis of the CFA of the isolates, is shown in Fig. 1a and b.
Figure 1a shows the complete collection of 58 isolates. The
cluster in the upper right quadrant represents the suspect out-
break strains (F), with the exception of the two mentioned
above as having discrepant susceptibility patterns. The previ-
ously nonsuspect patient (E) is in that cluster along with the
isolates from the UUHSC outpatient clinic (}) and the hos-
pital employee ().
Figure 1b shows a re-evaluation of the upper right cluster
shown in Fig. 1a. This graph was generated by Sherlock by
manually turning off all of the datum points except those rep-
resented by the symbols F, E, }, and . The program then
recalculated the principal components of this smaller set of
data and replotted their variability on the basis of the new
principal components 1 and 2, measured in Euclidian distance
(ED). MIDI defines strain level similarity as points covering an
area on the plot of less than 30 ED2. The one obvious outlying
point (}) represents the outpatient clinic strain and is outside
the 30 ED2 necessary for strain identity. All other isolates,
including the one previously epidemiologically nonassociated
inpatient and the health care worker, continued to appear
similar.
A representative example of PFGE results is shown in Fig. 2.
The patterns of all outbreak strains were identical, with the
exception of the same two strains identified as outliers by
Sherlock. The same previously nonsuspect patient which clus-
tered with the outbreak strains by Sherlock was also identified
by PFGE. The outpatient strain that was similar by Sherlock
showed differences in two bands by PFGE and would be con-
sidered distinct. All outliers varied by two or more bands.
DISCUSSION
Nosocomial infections are a major cause of morbidity, in-
volving more than 2 million patients annually at an estimated
cost of $4.5 billion in 1992 (4). Infection control measures have
been shown to effectively reduce nosocomial infections (14). In
recent years, epidemiologic investigations have utilized a vari-
ety of typing techniques to augment classical clinical analyses
(7, 8, 21, 31, 33). Since the UUHSC did not have a high
prevalence of MRSA, the outbreak afforded us the opportunity
to evaluate two laboratory methods in a clinically well-defined
epidemic.
The Kirby-Bauer susceptibility patterns of this group of or-
ganisms were eventually shown to correlate with their PFGE
and CFA types. Several outlying strains, however, varied by
only one drug and would have been difficult to identify as truly
different (32). Enhanced discriminatory power would be more
essential in centers with a high prevalence of MRSA.
Macrorestriction analysis of MRSA by PFGE has been eval-
uated in recent years and appears to be more sensitive than
other, more commonly utilized methods. Although PFGE has
been shown to provide more information than traditional typ-
ing methods, it is also time consuming and costly to run (2, 16).
Recent reports have shown some of the original steps to be
unnecessary, such as the use of proteinase K and the toxic
compound phenylmethylsulfonyl fluoride for its removal (6).
Our laboratory initiated PFGE by using more traditional ap-
proaches (22). The method presented herein evolved from an
effort to make PFGE more applicable to the work flow of a
busy clinical laboratory.
To our knowledge, this is the first report of the use of ACP
alone for lysis of staphylococci in agarose plugs. The lysis is
visually obvious and rapid. Murakami and Minamide (19) have
previously reported the use of this enzyme for lysis of S. aureus
prior to PCR detection of the mecA gene. We incubated the
lysis mixture at 508C on the basis of their recommendation.
The manufacturer’s application notes, however, cite proce-
dures in which lysis occurs with ACP at 378C (29, 34). Our own
experience has shown the plugs to be transparent when re-
moved from the refrigerator, illustrating the enzyme’s activity
over a very broad temperature range. The manufacturer’s
notes (34) state that ACP is most active in 0.01 M Tris HCl
buffer (pH 8.0) containing 0.01 M NaCl. Because ACP is very
sensitive to ionic strength (34), we found that when it was
suspended in this solution, it provided excellent clearing of
organisms. It produced poor or no clearing with the more
conventional TE/SDS (19) or EC (22) lysis solution. Even with
the rapid ACP lysis process, the PFGE procedure takes at least
48 h.
FIG. 1. Clustering of MRSA isolates by Sherlock two-dimensional plot.
Graph a shows the complete collection of 59 isolates. Graph b shows a re-
evaluation (see the explanation in the text) of the upper right cluster shown in
graph a. Note that several outbreak strains were superimposed on the two-
dimensional plot; therefore, the number of F symbols is less than the expected
43. Symbols: F, epidemiologically associated isolates from UUHSC; }, closely
related clinic isolate, not epidemiologically associated; E, isolate originally not
thought to be epidemiologically associated and indistinguishable by PFGE and
Sherlock; , hospital employee; p, isolates thought to be epidemiologically as-
sociated and proved dissimilar by PFGE and Sherlock; h, isolates from outside
clients (not UUHSC); n, UUHSC isolates not epidemiologically associated.
FIG. 2. Photograph showing a representative selection of isolates on PFGE.
Lane numbers: 1, lambda ladder marker (48.5-kb bacteriophage lambda DNA
concatemers); 2 to 7, isolates not epidemiologically associated; 8, isolate origi-
nally not thought to be epidemiologically associated and indistinguishable by
PFGE and Sherlock; 9, closely related clinic isolate not epidemiologically asso-
ciated; 10, hospital employee; 11 to 17, epidemiologically associated isolates
from UUHSC (surgical intensive care unit; lanes 11 and 12; medical intensive
care unit, lanes 13 and 14; burn unit, lanes 15 and 16; rehabilitation unit, lane 17);
18 to 19, isolates thought to be epidemiologically associated and proved dissim-
ilar by PFGE and Sherlock; 20, S. aureus NCTC 8325.
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The Sherlock method for CFA analysis and clustering is
rapid, easy to use, and after the initial instrument purchase,
cost effective. Although there is limited experience with the use
of CFA for comparison of clinical specimens (1, 10, 12, 18),
pharmaceutical and food industry quality control operations
have recently shown interest in using the Sherlock method to
track the source of contaminating organisms (24). As this
method appears promising, we decided to evaluate Sherlock
with our clinical outbreak.
Both Sherlock and PFGE rendered similar results which
correlated with the antibiograms. These typing methods both
identified the same two isolates, which were previously thought
to be epidemiologically associated, as different from the clus-
tered strains. Retrospectively, the Infection Control Practition-
er felt that these two patients were, in fact, questionably asso-
ciated with the outbreak. Similarly, both methods identified a
single isolate, not previously known to be involved with the
epidemic, that appeared to be identical to the clustered strains.
Again, the initial clinical impression of the association had
been unclear. The additional typing information provided bet-
ter definition of the outbreak. In addition, one of the known
outside isolates, from a UUHSC outpatient clinic, although
distinct, was surprisingly similar by PFGE, Sherlock, and anti-
biogram to the outbreak isolates. PFGE differed in the position
of only two bands. It is still not clear whether this represents an
example of the limited genetic diversity of MRSA or whether
this patient acquired the hospital strain on one of his many
visits to various UUHSC hospital clinics.
In our laboratory (Associated Regional and University Pa-
thologists, Inc.), we foresee the combined use of the two sys-
tems. The Sherlock system has the ability to screen large num-
bers of isolates and would easily accommodate duplicate
subcultures of the same isolate to ensure purity and reproduc-
ibility. In a recent study, 200 isolates were processed by a single
individual in 5 days (1). In the current effort, the unexpected
outliers were retested from the original stock cultures and
from intermediate subcultures with very similar results. One
obviously contaminated or mislabeled sample was also identi-
fied (data not shown). The original sample extracts were pre-
pared by three different individuals, showing good batch-to-
batch reproducibility.
Assuming that Sherlock could first identify gross outliers, the
laboratory could then be selective with the more costly and
labor-intensive PFGE as a confirmatory test for only the most
similar strains. For laboratories that have already invested in
the Sherlock system for microbial identification, the ability to
use the instrument for epidemiologic typing could be an added
advantage.
The information provided by these laboratory methods was
useful in focusing infection control efforts. The discriminatory
power, or the ability to differentiate among unrelated strains,
appeared to be comparable for both Sherlock and the better-
evaluated PFGE method with this single, well-defined out-
break. The Sherlock method appears to be promising as a
typing system, although more rigorous evaluation with ade-
quate numbers of epidemic and sporadic isolates is needed.
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